TATAA Biocenter and Strand Life Sciences Announce Strategic Partnership
News Jun 24, 2015
TATAA Biocenter has partnered with Strand Life Sciences to advance the analysis of Next Generation Sequencing (NGS) data.
As part of the partnership, TATAA Biocenter will distribute and support Strand NGS, Strand’s premier analysis tool for NGS data, in Europe. TATAA is also going to use Strand NGS in its popular NGS training courses.
“We always seek collaboration with the best solution providers for our training courses and Strand Life Sciences are top of the class for NGS whole transcriptome profiling”, says Kristina Lind, coordinator of TATAA Biocenter’s hands-on training program. “Our customers request professional tools for the entire NGS workflow from sample preparation, quality control, library preparation, sequencing and data analysis.”, says Mikael Kubista, president of TATAA Biocenter, “With Strand NGS our customers obtain the most comprehensive and powerful tool for the analysis of Next Generation Sequencing data”.
“We have always welcomed collaborations for serving the customer better and for the greater good of science. Tataa Biocenter is an established player in Europe with a wide reach. European customers will now have access to one of the most comprehensive, commercially available, NGS analysis tools” says Scott Storrer, President of Strand Life Science.
Giant Viruses Invent Their Own GenesNews
Three new members have been isolated and added to the Pandoravirus family. This strange family of viruses, with their giant genomes and many genes with no known equivalents, surprised scientists when they were discovered a few years ago. This new study notes that pandoraviruses appear to be factories for new genes – and therefore new functions.
Therapeutic CRISPR Could Be Cancer RiskNews
Therapeutic use of gene editing with the so-called CRISPR-Cas9 technique may inadvertently increase the risk of cancer, according to a new study. Researchers say that more studies are required in order to guarantee the safety of these ‘molecular scissors’ for gene-editing therapies.